












Bone loss is associated with osteoporosis a disease where decreasing bone density makes bones brittle and prone to fractures. BMD uses very low dose X-rays to evaluate bone mineralisation and hence predict fracture risk, allowing prevention therapy for osteoporosis to be started or modified.
BMD should be considered in normal healthy middle-aged men and women as a baseline, or in patients where disease or therapeutic interventions affect bone density and metabolism.
